See more : Geospace Technologies Corporation (GEOS) Income Statement Analysis – Financial Results
Complete financial analysis of Raffles Medical Group Ltd (RAFLF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Raffles Medical Group Ltd, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- PT Envy Technologies Indonesia Tbk (ENVY.JK) Income Statement Analysis – Financial Results
- LiveWorld, Inc. (LVWD) Income Statement Analysis – Financial Results
- Independence Gold Corp. (IGO.V) Income Statement Analysis – Financial Results
- TCI Express Limited (TCIEXP.NS) Income Statement Analysis – Financial Results
- Nordea Invest Emerging Markets (NDIEMKL1.CO) Income Statement Analysis – Financial Results
Raffles Medical Group Ltd (RAFLF)
About Raffles Medical Group Ltd
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte. Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 536.53M | 571.22M | 536.40M | 429.92M | 388.23M | 358.87M | 357.37M | 327.82M | 289.38M |
| Cost of Revenue | 297.12M | 378.95M | 422.11M | 350.30M | 302.76M | 267.04M | 266.55M | 240.92M | 209.70M |
| Gross Profit | 239.41M | 192.28M | 114.29M | 79.62M | 85.47M | 91.83M | 90.81M | 86.91M | 79.69M |
| Gross Profit Ratio | 44.62% | 33.66% | 21.31% | 18.52% | 22.01% | 25.59% | 25.41% | 26.51% | 27.54% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 107.94M | 36.99M | 30.87M | 29.31M | 30.61M | 34.27M | 33.54M | 32.52M | 25.22M |
| Other Expenses | 43.76M | 1.05M | 667.73K | 2.17M | 690.14K | 1.87M | 559.71K | 0.00 | 0.00 |
| Operating Expenses | 151.69M | 35.94M | 30.20M | 27.14M | 29.92M | 32.40M | 32.98M | 32.52M | 25.22M |
| Cost & Expenses | 448.81M | 414.89M | 452.31M | 377.44M | 332.68M | 299.44M | 299.53M | 273.44M | 234.91M |
| Interest Income | 7.39M | 2.04M | 469.86K | 870.12K | 1.70M | 794.57K | 700.39K | 787.71K | 773.98K |
| Interest Expense | 4.60M | 5.13M | 4.71M | 3.90M | 1.94M | 868.67K | 666.72K | 419.46K | 66.97K |
| Depreciation & Amortization | 18.73M | 29.16M | 29.14M | 26.86M | 21.76M | 13.41M | 11.22M | 10.15M | 9.03M |
| EBITDA | 100.70M | 175.77M | 119.51M | 79.34M | 79.67M | 72.84M | 71.85M | 67.66M | 66.62M |
| EBITDA Ratio | 18.77% | 32.62% | 21.11% | 18.45% | 19.91% | 20.30% | 19.32% | 19.69% | 21.94% |
| Operating Income | 87.72M | 156.34M | 84.10M | 52.48M | 55.55M | 59.43M | 57.83M | 54.39M | 54.47M |
| Operating Income Ratio | 16.35% | 27.37% | 15.68% | 12.21% | 14.31% | 16.56% | 16.18% | 16.59% | 18.82% |
| Total Other Income/Expenses | 2.79M | -13.48M | -35.65M | -3.07M | -19.70M | -77.73K | -19.61M | 984.00K | 1.00M |
| Income Before Tax | 90.51M | 142.86M | 85.66M | 63.89M | 56.46M | 61.73M | 60.47M | 57.40M | 57.52M |
| Income Before Tax Ratio | 16.87% | 25.01% | 15.97% | 14.86% | 14.54% | 17.20% | 16.92% | 17.51% | 19.88% |
| Income Tax Expense | 21.48M | 35.77M | 23.62M | 14.96M | 11.45M | 9.78M | 9.10M | 10.37M | 8.86M |
| Net Income | 68.31M | 106.95M | 62.38M | 49.86M | 44.82M | 52.13M | 52.96M | 48.60M | 48.84M |
| Net Income Ratio | 12.73% | 18.72% | 11.63% | 11.60% | 11.55% | 14.53% | 14.82% | 14.82% | 16.88% |
| EPS | 0.04 | 0.06 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
| EPS Diluted | 0.04 | 0.06 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
| Weighted Avg Shares Out | 1.86B | 1.86B | 1.87B | 1.84B | 1.81B | 1.78B | 1.76B | 1.74B | 1.71B |
| Weighted Avg Shares Out (Dil) | 1.87B | 1.87B | 1.88B | 1.84B | 1.82B | 1.79B | 1.77B | 1.75B | 1.73B |
Source: https://incomestatements.info
Category: Stock Reports